Potential hazards of combination immunotherapy in the treatment of experimental septic shock. [electronic resource]
Producer: 19960725Description: 1415-21 p. digitalISSN:- 0022-1899
- Animals
- Bacteremia -- blood
- Carrier Proteins -- adverse effects
- Colony Count, Microbial
- Cyclophosphamide -- pharmacology
- Drug Therapy, Combination
- Endotoxins -- blood
- Humans
- Immunosuppressive Agents -- pharmacology
- Immunotherapy -- adverse effects
- Interleukin 1 Receptor Antagonist Protein
- Interleukin-1
- Neutropenia -- chemically induced
- Polyethylene Glycols -- chemistry
- Pseudomonas Infections -- pathology
- Pseudomonas aeruginosa -- growth & development
- Rats
- Receptors, Tumor Necrosis Factor
- Receptors, Tumor Necrosis Factor, Type I
- Recombinant Proteins -- adverse effects
- Shock, Septic -- pathology
- Sialoglycoproteins -- adverse effects
- Tumor Necrosis Factor Decoy Receptors
- Tumor Necrosis Factor-alpha -- analysis
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.